Scripps Research

Shanghai Ark Biopharmaceutical Co., Ltd announced that it has renewed its co-development collaboration with Calibr, a division of Scripps Research, to develop AK0705, a potential first-in-class drug targeting an enzyme that plays a crucial role in respiratory inflammation. The drug is intended to treat a broad spectrum of respiratory diseases,…